Publication: Cancers in the TREAT Asia HIV Observational Database (TAHOD): A retrospective analysis of risk factors
Issued Date
2010-12-13
Resource Type
ISSN
17582652
Other identifier(s)
2-s2.0-78649783908
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the International AIDS Society. Vol.13, No.1 (2010)
Suggested Citation
Kathy Petoumenos, Eugenie Hui, Nagalingeswaran Kumarasamy, Stephen J. Kerr, Jun Yong Choi, Yi Ming A. Chen, Tuti Merati, Fujie Zhang, Poh Lian Lim, Somnuek Sungkanuparph, Sanjay Pujari, Sasheela Ponnampalavanar, Rosanna Ditangco, Christopher Kc Lee, Andrew Grulich, Matthew G. Law Cancers in the TREAT Asia HIV Observational Database (TAHOD): A retrospective analysis of risk factors. Journal of the International AIDS Society. Vol.13, No.1 (2010). doi:10.1186/1758-2652-13-51 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/29344
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Cancers in the TREAT Asia HIV Observational Database (TAHOD): A retrospective analysis of risk factors
Other Contributor(s)
University of New South Wales (UNSW) Australia
Queen Elizabeth Hospital Hong Kong
YR Gaitonde Centre for AIDS Research and Education
The HIV Netherlands Australia Thailand Research Collaboration
Yonsei University College of Medicine
National Yang-Ming University Taiwan
Universitas Udayana
Beijing Ditan Hospital
Tan Tock Seng Hospital
Mahidol University
Institute of Infectious Diseases
University of Malaya Medical Centre
Gokila
Hospital Sungai Buloh
Queen Elizabeth Hospital Hong Kong
YR Gaitonde Centre for AIDS Research and Education
The HIV Netherlands Australia Thailand Research Collaboration
Yonsei University College of Medicine
National Yang-Ming University Taiwan
Universitas Udayana
Beijing Ditan Hospital
Tan Tock Seng Hospital
Mahidol University
Institute of Infectious Diseases
University of Malaya Medical Centre
Gokila
Hospital Sungai Buloh
Abstract
Background. This retrospective survey describes types of cancers diagnosed in HIV-infected subjects in Asia, and assesses risk factors for cancer in HIV-infected subjects using contemporaneous HIV-infected controls without cancer. Methods. TREAT Asia HIV Observational Database (TAHOD) sites retrospectively reviewed clinic medical records to determine cancer diagnoses since 2000. For each diagnosis, the following data were recorded: date, type, stage, method of diagnosis, demographic data, medical history, and HIV-related information. For risk factor analyses, two HIV-infected control subjects without cancer diagnoses were also selected. Cancers were grouped as AIDS-defining cancers (ADCs), and non-ADCs. Non-ADCs were further categorized as being infection related (NADC-IR) and unrelated (NADC-IUR). Results. A total of 617 patients were included in this study: 215 cancer cases and 402 controls from 13 sites. The majority of cancer cases were male (71%). The mean age (SD) for cases was 39 (10.6), 46 (11.5) and 44 (13.7) for ADCs, NADC-IURs and NADCs-IR, respectively. The majority (66%) of cancers were ADCs (16% Kaposi sarcoma, 40% non-Hodgkin's lymphoma, and 9% cervical cancer). The most common NADCs were lung (6%), breast (5%) and hepatocellular carcinoma and Hodgkin's lymphoma (2% each). There were also three (1.4%) cases of leiomyosarcoma reported in this study. In multivariate analyses, individuals with CD4 counts above 200 cells/mm3were approximately 80% less likely to be diagnosed with an ADC (p < 0.001). Older age (OR: 1.39, p = 0.001) and currently not receiving antiretroviral treatment (OR: 0.29, p = 0.006) were independent predictors of NADCs overall, and similarly for NADCs-IUR. Lower CD4 cell count and higher CDC stage (p = 0.041) were the only independent predictors of NADCs-IR. Conclusions. The spectrum of cancer diagnoses in the Asia region currently does not appear dissimilar to that observed in non-Asian HIV populations. One interesting finding was the cases of leiomyosarcoma, a smooth-muscle tumour, usually seen in children and young adults with AIDS, yet overall quite rare. Further detailed studies are required to better describe the range of cancers in this region, and to help guide the development of screening programmes. © 2010 Petoumenos et al; licensee BioMed Central Ltd.